Besponsa (Inotuzumab Ozogamicin) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Besponsa. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Inotuzumab ozogamicin.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Inotuzumab ozogamicin.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Inotuzumab ozogamicin is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Inotuzumab ozogamicin.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Inotuzumab ozogamicin is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Inotuzumab ozogamicin.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Inotuzumab ozogamicin.
Level 2 evidence
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Inotuzumab ozogamicin.
Level 1 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Inotuzumab ozogamicin is combined with Aceclofenac.
Level 2 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Inotuzumab ozogamicin.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Inotuzumab ozogamicin.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Inotuzumab ozogamicin.
Besponsa (Inotuzumab Ozogamicin) has 1074 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Besponsa (Inotuzumab Ozogamicin) has 6 major, 920 moderate, and 148 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Besponsa. Always confirm against the full prescribing information.